Phase 3 trial evaluating efficacy and safety of odronextamab plus CHOP vs rituximab plus CHOP in previously untreated diffuse large B-cell lymphoma (DLBCL; OLYMPIA-3).

Matasar, MatthewTurgut, BurhanTessoulin, BenoitGuidez, StephanieAltuntas, FevziIqbal, NaziaNamuduri, Manjusha2024-10-292024-10-2920240732-183X1527-7755https://hdl.handle.net/20.500.11776/14165Special Clinical Science Symposia -- MAY 29-29, 2024 -- ELECTR NETWORK[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessPhase 3 trial evaluating efficacy and safety of odronextamab plus CHOP vs rituximab plus CHOP in previously untreated diffuse large B-cell lymphoma (DLBCL; OLYMPIA-3).Conference Object4216N/AWOS:001275557406337